Santiago
Moreno Guillén
Catedrático/a de Universidad
Enrique
Navas Elorza
Publicaciones en las que colabora con Enrique Navas Elorza (45)
2021
-
COVID-19 and geographical area of origin
Clinical Microbiology and Infection, Vol. 27, Núm. 4, pp. 632.e1-632.e5
2020
-
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
The Lancet HIV, Vol. 7, Núm. 8, pp. e554-e564
2019
-
Impact of a structured HIV testing program in a hospital emergency department and a primary care center
PLoS ONE, Vol. 14, Núm. 8
2018
-
Análisis retrospectivo de los casos de endocarditis infecciosa a lo largo de 31 años (1985-2016) en un Hospital Terciario (Ramón y Cajal)
RIECS: Revista de Investigación y Educación en Ciencias de la Salud, Vol. 3, Núm. 1, pp. 22-33
2017
-
Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253
2015
-
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784
2014
-
Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 33, Núm. 2, pp. 179-187
-
Development of tuberculosis in human immunodeficiency virus infected patients receiving antiretroviral therapy
International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 9, pp. 1080-1084
-
Extra-pulmonary tuberculosis: Differential aspects and role of 16S-rRNA in urine
International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 4, pp. 478-485
-
Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio
PLoS ONE, Vol. 9, Núm. 1
2013
-
Infective endocarditis in congenital heart disease: A frequent community-acquired complication
Infection, Vol. 41, Núm. 1, pp. 167-174
-
Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infections
Clinical Infectious Diseases, Vol. 57, Núm. 3, pp. 458-464
2011
-
Changes in the epidemiology of tuberculosis: The influence of international migration flows
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 9, pp. 654-659
-
Incidence of tuberculosis in HIV-infected patients receiving HAART: Interaction between TST and CD4 count
International Journal of Tuberculosis and Lung Disease, Vol. 15, Núm. 10, pp. 1347-1352
-
Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: Effect on T cells latently infected
PLoS ONE, Vol. 6, Núm. 12
2010
-
Infección por "mycobacterium tuberculosis"
Medicine: Programa de Formación Médica Continuada Acreditado, Serie 10, Núm. 56, pp. 3808-3819
-
Mycobacterium tuberculosis infection
Medicine, Vol. 10, Núm. 56, pp. 3808-3819
2009
-
Observational study to evaluate clinical outcomes after first-line efavirenz-or Lopinavir-Ritonavir-based HAART in treatment-naive patients
Journal of the International Association of Physicians in AIDS Care, Vol. 8, Núm. 5, pp. 308-313
2007
-
Epidemiology and clinical features of tuberculosis in immigrants at an infectious diseases department in Madrid
International Journal of Tuberculosis and Lung Disease, Vol. 11, Núm. 7, pp. 769-774
-
Sputum conversion among patients with pulmonary tuberculosis: Are there implications for removal of respiratory isolation?
Journal of Antimicrobial Chemotherapy, Vol. 59, Núm. 4, pp. 794-798